Roger is just showing his optimism. He is the CEO and he wants results. No different than any other CEO. But trust me, the clinical research process for drug therapies is always tedious, especially for new therapies and especially in oncology. I've worked on drug studies as simple as antihistamines for allergic rhinitis and they take time. Phase 1b is way early in the process. Be patient.
Market Data 
Markets 
AI
